15//02//12
Biotech Breakfast Briefing in London
Biotech reinvented: Where do you go from here?
Thursday 8th March, 8:30 am – 9:30 am.
QMB Innovation Centre
1 Walden Street, London E1 2AL
Agenda
Welcome by hosts: QMB Innovation Centre
Introduction to session by Sponsors: Dorsey & Whitney LLP
Presentation: Biotech Reinvented: Where do you go from here? ~ Jo Pisani, Partner at PwC
Panel Session: Biotech CPR! What can we do? ~ Chaired by Fran Doherty, Partner at Dorsey & Whitney LLP
Potential Discussion points:
PwC discussion key points: Biotech, as a business model is broken. Why?
- The research base is shifting geographically to the East
- Governments in these emerging regions are investing heavily
- VCs, especially in Europe, are becoming impatient with Biotech
- Corporate VCs are emerging as key investors and the public markets have closed to such risky investments
- The development of substantial infrastructure surrounding these companies is now considered unnecessary
Panel Discussion: Biotech CPR? What can we do?!
Panel Members:
Brian Horsburgh, Head of Life Sciences at IP Group
Sacha Mann, Principal, Inventages
Tbc
- Will a collaborative model address changing trends and value propositions?
- Increasing R&D productivity?
- Focusing on a business model that is realistic, .i.e., that your exit is a sale. (Over half of the mergers and acquisitions now are not coming from Big Pharma- a great time for biotech acquisitions)
- A new model for Biotech Investing?
Please RSVP Anna to attend this event: a.miszczuk@qmul.ac.uk
This event is sponsored by Dosey & Whitney LLP